Welcome

Welcome to my blog on the latest happening in the regulatory realm of Life Science globally. Although the scope of this blog is more than just eCTD, that is clearly one of the main topics in the industry, and right now it will be difficult to totally remove our focus from that area completely.

With the transition to eCTD, more and more companies are reevaluating other relevant portions of their business, notably document management, document authoring, and drug labels which will be approved by the agency. Ideally this blog will provide an area to record and share thoughts about these trends, their implication and the technology that will shape the way life sciences organizations do business today and tomorrow.